Targeted Anticytokine Therapy in Patients With Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)

By Douglas L. Mann, J. McMurray, M. Packer, K. Swedberg, J. Borer, W. Colucci, J. Djian, H. Drexler, A. Feldman, L. Køber and 10 more. Circulation, 2004

1,254 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Oncology

View Paper: https://www.semanticscholar.org/paper/028377babdeeefbf5ca1ba60ee79289e584884eb

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. M. Genovese
2. E. S. St Clair
3. J. Kremer
4. J. Bathon
5. L. Fraenkel
6. B. England
7. J. Sparks
8. Mary C. Nakamura

Citations in the corpus

• 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis (2021, background): “These recommendations are based on the risk of worsening heart failure observed in randomized clinical trials of TNF inhibitors in patients with NYHA class III or IV heart failure without RA (46,47).”